Cargando…
Soluble fibrinogen-like protein 2 levels are decreased in patients with ischemic heart failure and associated with cardiac function
Soluble fibrinogen-like protein 2 (sFGL2), as a novel effector of regulatory T cells (Tregs), exhibits immune regulatory activity in several inflammatory diseases. Immune activation and persistent inflammation participate in the progression of ischemic heart failure (IHF). The present study aimed to...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188637/ https://www.ncbi.nlm.nih.gov/pubmed/34109427 http://dx.doi.org/10.3892/mmr.2021.12198 |